Preschool outcomes following prenatal serotonin reuptake inhibitor exposure: Differences in language and behavior, but not cognitive function

Katrina C. Johnson, Alicia K. Smith, Zachary N. Stowe, Donald J Newport, Patricia A. Brennan

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Objective: To test the hypothesis that prenatal exposure to serotonin reuptake inhibitors (SRIs) is associated with language and behavioral outcomes in preschoolaged children, while accounting for confounds such as concomitant exposures and maternal mental illness. Method: An observational, prospective, longitudinal study of mental illness in pregnancy was conducted at a universitybased women's mental health clinic (April 2010November 2012). A sample of 178 mother-child dyads participated in a laboratory visit at preschool age (2.55.5 years). The majority of women (87%) received psychotropic medication during pregnancy. Psychiatric status (based on DSM-IV), other medication use, and substance use were serially assessed and tested as confounds. Primary outcome measures included standardized measures of expressive language and cognitive function and mother and alternate caregiver ratings of child behavior problems, including the Pervasive Developmental Disorders (PDD) subscale of the Child Behavior Checklist. Results: Linear regression analyses revealed that, after controlling for relevant covariates, expressive language scores from the Test of Early Language Development, 3rd edition, were negatively associated with prenatal SRI exposure (= 0.15, t = 2.41), while the PDD behavioral problems subscales completed by alternate caregivers and mothers were positively associated with prenatal SRI exposure (= 0.17, t = 2.01; = 0.16, t = 2.00, respectively). Cognitive function, measured using the Differential Ability Scales, 2nd edition, was not associated with any medication exposures. Conclusions: The current data suggest a small but significant association between prenatal SRI exposure and preschool outcomes, including expressive language and behavior problems. These data corroborate data from recent, population-based studies, although overall, published findings are mixed. Replication and identification of moderating risk factors are needed to understand potential clinical implications.

Original languageEnglish (US)
Pages (from-to)e176-e182
JournalJournal of Clinical Psychiatry
Volume77
Issue number2
DOIs
StatePublished - Feb 1 2016

Fingerprint

Serotonin Uptake Inhibitors
Cognition
Language
Mothers
Caregivers
Child Behavior Disorders
Language Tests
Maternal Exposure
Pregnancy
Language Development
Aptitude
Child Behavior
Women's Health
Checklist
Diagnostic and Statistical Manual of Mental Disorders
Psychiatry
Longitudinal Studies
Linear Models
Mental Health
Regression Analysis

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Preschool outcomes following prenatal serotonin reuptake inhibitor exposure : Differences in language and behavior, but not cognitive function. / Johnson, Katrina C.; Smith, Alicia K.; Stowe, Zachary N.; Newport, Donald J; Brennan, Patricia A.

In: Journal of Clinical Psychiatry, Vol. 77, No. 2, 01.02.2016, p. e176-e182.

Research output: Contribution to journalArticle

Johnson, Katrina C. ; Smith, Alicia K. ; Stowe, Zachary N. ; Newport, Donald J ; Brennan, Patricia A. / Preschool outcomes following prenatal serotonin reuptake inhibitor exposure : Differences in language and behavior, but not cognitive function. In: Journal of Clinical Psychiatry. 2016 ; Vol. 77, No. 2. pp. e176-e182.
@article{3b5e9d968e2347f080053428b6544fff,
title = "Preschool outcomes following prenatal serotonin reuptake inhibitor exposure: Differences in language and behavior, but not cognitive function",
abstract = "Objective: To test the hypothesis that prenatal exposure to serotonin reuptake inhibitors (SRIs) is associated with language and behavioral outcomes in preschoolaged children, while accounting for confounds such as concomitant exposures and maternal mental illness. Method: An observational, prospective, longitudinal study of mental illness in pregnancy was conducted at a universitybased women's mental health clinic (April 2010November 2012). A sample of 178 mother-child dyads participated in a laboratory visit at preschool age (2.55.5 years). The majority of women (87{\%}) received psychotropic medication during pregnancy. Psychiatric status (based on DSM-IV), other medication use, and substance use were serially assessed and tested as confounds. Primary outcome measures included standardized measures of expressive language and cognitive function and mother and alternate caregiver ratings of child behavior problems, including the Pervasive Developmental Disorders (PDD) subscale of the Child Behavior Checklist. Results: Linear regression analyses revealed that, after controlling for relevant covariates, expressive language scores from the Test of Early Language Development, 3rd edition, were negatively associated with prenatal SRI exposure (= 0.15, t = 2.41), while the PDD behavioral problems subscales completed by alternate caregivers and mothers were positively associated with prenatal SRI exposure (= 0.17, t = 2.01; = 0.16, t = 2.00, respectively). Cognitive function, measured using the Differential Ability Scales, 2nd edition, was not associated with any medication exposures. Conclusions: The current data suggest a small but significant association between prenatal SRI exposure and preschool outcomes, including expressive language and behavior problems. These data corroborate data from recent, population-based studies, although overall, published findings are mixed. Replication and identification of moderating risk factors are needed to understand potential clinical implications.",
author = "Johnson, {Katrina C.} and Smith, {Alicia K.} and Stowe, {Zachary N.} and Newport, {Donald J} and Brennan, {Patricia A.}",
year = "2016",
month = "2",
day = "1",
doi = "10.4088/JCP.14m09348",
language = "English (US)",
volume = "77",
pages = "e176--e182",
journal = "Journal of Clinical Psychiatry",
issn = "0160-6689",
publisher = "Physicians Postgraduate Press Inc.",
number = "2",

}

TY - JOUR

T1 - Preschool outcomes following prenatal serotonin reuptake inhibitor exposure

T2 - Differences in language and behavior, but not cognitive function

AU - Johnson, Katrina C.

AU - Smith, Alicia K.

AU - Stowe, Zachary N.

AU - Newport, Donald J

AU - Brennan, Patricia A.

PY - 2016/2/1

Y1 - 2016/2/1

N2 - Objective: To test the hypothesis that prenatal exposure to serotonin reuptake inhibitors (SRIs) is associated with language and behavioral outcomes in preschoolaged children, while accounting for confounds such as concomitant exposures and maternal mental illness. Method: An observational, prospective, longitudinal study of mental illness in pregnancy was conducted at a universitybased women's mental health clinic (April 2010November 2012). A sample of 178 mother-child dyads participated in a laboratory visit at preschool age (2.55.5 years). The majority of women (87%) received psychotropic medication during pregnancy. Psychiatric status (based on DSM-IV), other medication use, and substance use were serially assessed and tested as confounds. Primary outcome measures included standardized measures of expressive language and cognitive function and mother and alternate caregiver ratings of child behavior problems, including the Pervasive Developmental Disorders (PDD) subscale of the Child Behavior Checklist. Results: Linear regression analyses revealed that, after controlling for relevant covariates, expressive language scores from the Test of Early Language Development, 3rd edition, were negatively associated with prenatal SRI exposure (= 0.15, t = 2.41), while the PDD behavioral problems subscales completed by alternate caregivers and mothers were positively associated with prenatal SRI exposure (= 0.17, t = 2.01; = 0.16, t = 2.00, respectively). Cognitive function, measured using the Differential Ability Scales, 2nd edition, was not associated with any medication exposures. Conclusions: The current data suggest a small but significant association between prenatal SRI exposure and preschool outcomes, including expressive language and behavior problems. These data corroborate data from recent, population-based studies, although overall, published findings are mixed. Replication and identification of moderating risk factors are needed to understand potential clinical implications.

AB - Objective: To test the hypothesis that prenatal exposure to serotonin reuptake inhibitors (SRIs) is associated with language and behavioral outcomes in preschoolaged children, while accounting for confounds such as concomitant exposures and maternal mental illness. Method: An observational, prospective, longitudinal study of mental illness in pregnancy was conducted at a universitybased women's mental health clinic (April 2010November 2012). A sample of 178 mother-child dyads participated in a laboratory visit at preschool age (2.55.5 years). The majority of women (87%) received psychotropic medication during pregnancy. Psychiatric status (based on DSM-IV), other medication use, and substance use were serially assessed and tested as confounds. Primary outcome measures included standardized measures of expressive language and cognitive function and mother and alternate caregiver ratings of child behavior problems, including the Pervasive Developmental Disorders (PDD) subscale of the Child Behavior Checklist. Results: Linear regression analyses revealed that, after controlling for relevant covariates, expressive language scores from the Test of Early Language Development, 3rd edition, were negatively associated with prenatal SRI exposure (= 0.15, t = 2.41), while the PDD behavioral problems subscales completed by alternate caregivers and mothers were positively associated with prenatal SRI exposure (= 0.17, t = 2.01; = 0.16, t = 2.00, respectively). Cognitive function, measured using the Differential Ability Scales, 2nd edition, was not associated with any medication exposures. Conclusions: The current data suggest a small but significant association between prenatal SRI exposure and preschool outcomes, including expressive language and behavior problems. These data corroborate data from recent, population-based studies, although overall, published findings are mixed. Replication and identification of moderating risk factors are needed to understand potential clinical implications.

UR - http://www.scopus.com/inward/record.url?scp=84959529302&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84959529302&partnerID=8YFLogxK

U2 - 10.4088/JCP.14m09348

DO - 10.4088/JCP.14m09348

M3 - Article

C2 - 26930533

AN - SCOPUS:84959529302

VL - 77

SP - e176-e182

JO - Journal of Clinical Psychiatry

JF - Journal of Clinical Psychiatry

SN - 0160-6689

IS - 2

ER -